Renal cell carcinoma

Образовательная цель: To assess the recurrence risk after nephrectomy and appropriately select patients who are at high risk of renal cell carcinoma (RCC) recurrence and may benefit from adjuvant treatment.

Специальность: Urology, Medical oncology, Clinical oncology

Целевая аудитория : Specialists (CME: basic, intermediate), Residents (senior)

Самое последнее обновление : January 2025

Фон:

Regulatory approval status of drugs mentioned in this CME course, restricted to the adjuvant treatment setting (status 22 January 2025)

This educational platform includes case challenges with treatment options that may not be indicated for this use in your country. Please refer to your local prescribing information.